Rarely are TP53 mutations investigated in HBC/HBOC families due the estimated low frequency (<1%) of carriers in breast cancer cases and the observation that 70% of carriers are found in Li-Fraumeni Syndrome (LFS) families [1]. The gene discussed is TP53; the disease is breast cancer.